The global flow cytometry market size is forecasted to grow to USD 4.71 Million in 2022 and reach USD 7.77 Million by 2027. This market is growing at a CAGR of 10.5% during the forecast period.
Based on technology, the cell-based segment emerged as the largest segment and occupied 77.56% market share in 2021.
Based on application, the clinical segment dominated the market by capturing 47.2% of the market share in 2021.
The North American flow cytometry market is anticipated to be worth USD 2574.49 million by 2027
the Asia pacific flow cytometry market is projected to grow the highest with a CAGR of 12.50 during the forecast period.
Flow cytometry is a laser-based biophysical methodical technology that procedures and examines several physical features of particles postponed in a fluid as they pass through a laser beam. Flow cytometry has several advantages over traditional analytical methods, such as ELISA, including its ability to provide accurate and precise results. In addition, it is less time-consuming at the same price approximately. As a result, flow cytometry technology is used in several areas of academic research and diagnosis of HIV, hematologic malignancies, and cancer.
COVID-19 Impact on the global flow cytometry market:
The researchers have conducted many R&Ds to study the virus and the disease it causes. An increasing number of clinical trials for possible drug treatment. Several research institutes and biopharmaceutical companies are doing extensive research activities to develop new Vaccines and therapies, and demand for flow cytometry increased. Moreover, flow cytometry techniques in COVID-19 research activities and clinical trials have provided opportunities for a wide range of market players. The outbreak of COVID-19 led to the high growth of the flow cytometry market. The market is expected to register healthy growth during the forecast period.
MARKET DRIVERS:
Y-O-Y rise in the occurrence rate of chronic and infectious diseases such as cancer and HIV are majorly driving the global flow cytometry market growth.
Technological advancements, growing acquisition in cytometry techniques, increasing market perforation in existing countries, and growth in stem cell research and acquisition of recombination of DNA technologies for antibody protection are further likely to augment the growth rate of the flow cytometry market.
MARKET RESTRAINTS:
The restraining factors that challenge the growth of the flow cytometry market are the availability of alternate and cheaper techniques, high costs associated with flow cytometry reagents and instruments, budget restrictions for research purposes, and expensive installation and maintenance costs.
High costs associated and the scarcity of labour and skilled technicians in the lab and clinics also hamper the flow cytometry market growth. Additionally, the lack of awareness among the end-users and less accessibility of technical expertise further restrained the market growth during the analysis period.
REPORT COVERAGE:
REPORT METRIC |
DETAILS |
Market Size Available |
2021 to 2027 |
Base Year |
2021 |
Forecast Period |
2022 to 2027 |
Segments Covered |
By Technology, Product, Application, End-User, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
This market research report on the global flow cytometry market has been segmented and sub-segmented based on technology, product, application, end-user, and region.
Flow Cytometry Market - By Technology:
Based on technology, the bead-based technology segment is dominating the market. Moreover, it is to increase during the forecast period due to market boosting like high speed and stability, high reproducibility, and the ability to detect multiple analytes.
The bead-based segment is considered to have fast growth in the flow cytometry market over the analysis period. The segment growth owes to procedural advantages over cell-based techniques.
Flow Cytometry Market - By Product:
Based on the product, the reagents & consumables segment accounts for the most significant global market share in 2020. The segment growth owes to extensive usage of diagnostic applications, research on cell biology and immunology, commercialization, and development of reagents and assays with better quality are expected to fuel the flow cytometry market growth.
The instruments segment is predicted to have the quickest growth in the market over the forecast period due to the launch of novel technologies, correct results, and user-friendliness.
Flow Cytometry Market - By Application:
Flow Cytometry Market - By End-users:
Based on the end-user, the commercial organization's segment is considered to have the largest share of the flow cytometry market due to various applications such as food microbiology, blood banks, and plant cell culture.
The clinical testing labs segment is considered to have fast growth in flow cytometry over the forecast period, and the increase is due to an increasing number of chronic diseases. In addition, a rise in organ transplantation practices helps market growth over the forecast period.
Flow Cytometry Market - By Region:
Regionally, the North American flow cytometry market accounted for the largest share of the global market in 2021, followed by Europe.
The Europe flow cytometry market is expected to perform well during the forecast period and is the second leading region, followed by North America in 2021. Factors like stem cell research, the existence of new and advanced technologies in cytometry, and the surge in the application during clinical research are strongly surging the market demand in Europe. As a result, the U.K. is expected to lead the European flow cytometry market during the forecast period.
The Flow Cytometry market in the Asia-Pacific region to growing at the highest CAGR, which is significant due to the increasing development and production of new biologics, vaccines, and drugs, expanding medical treatment for infectious and chronic diseases, the rising median age of the population, and increasing focus on attracting international and domestic players in the market.
The Flow Cytometry market in the Latin America region is expected to showcase a steady growth rate during the forecast period. The market growth in this region is attributed to factors such as the growing rise of HIV and cancer cases. The increased use of flow cytometry for drug discovery is expected to fuel the market of this region. Mexico is the leading country in the region due to the high occurrence of cancer growth.
The MEA flow cytometry market is expected to grow at a CAGR of 10.3% during the forecast period.
KEY MARKET PARTICIPANTS:
Noteworthy companies operating in the global flow cytometry market profiled in this report are Becton, Dickinson, and Company., Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Sysmex Partec GmbH, Luminex Corporation, Miltenyi Biotec GmbH, Bio-Rad Laboratories, Inc., Sony Biotechnology, Life Technologies Corporation Inc., EMD Millipore Corporation, Miltenyi Biotec, Agilent Technologies, Inc. and Affymetix Inc.
RECENT MARKET DEVELOPMENTS:
FAQ's
As per our research report, the global flow cytometry market size is projected to be USD 7773 Million by 2027.
Geographically, the North American flow cytometry market accounted for the largest share of the global market in 2021.
The global flow cytometry market is estimated to grow at a CAGR of 10.5% from 2022 to 2027.
Thermo Fisher Scientific, Inc., Merck KGaA, Sysmex Partec GmbH, Luminex Corporation, Miltenyi Biotec GmbH, Bio-Rad Laboratories, Inc., Sony Biotechnology, Life Technologies Corporation Inc are some of the significant players operating in flow cytometry market
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com